Oncology Medical News about acute myeloid leukemia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

GM-CSF secreting cellular immunotherapy in combination with autologous stem cell transplant (ASCT) as post-remission therapy for acute myeloid leukemia (AML)
Blood, 06/29/09

Borrello IM et al. - A decrease in WT1 transcripts in blood was noted in 69% of patients following the first immunotherapy dose and was also associated with longer 3-year RFS (61% vs. 0%). In conclusion, immunotherapy in combination with primed lymphocytes and ASCT shows encouraging signals of potential activity in AML.

<< Previous
Pre-clinical characterization of 1-7F9, a novel human anti-KIR...

Next >>
TLR7 stimulation in human plasmacytoid dendritic cells leads to...